Wordt geladen...
Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension
PURPOSE: To evaluate the additive intraocular pressure–lowering effect of twice-daily brinzolamide 1%/brimonidine 0.2% fixed-dose combination (BBFC) as an adjunct to a prostaglandin analog (PGA) in patients with open-angle glaucoma or ocular hypertension insufficiently controlled with PGA monotherap...
Bewaard in:
| Gepubliceerd in: | Eur J Ophthalmol |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
SAGE Publications
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859663/ https://ncbi.nlm.nih.gov/pubmed/31595773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1120672119878044 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|